Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Clinical Evaluation of the RH210 Hearing Aid

NCT: NCT07572357 · RECRUITING

NCT IDNCT07572357
StatusRECRUITING
Start Date2026-04-11
Completion2026-08-30
SponsorRehear Audiology Company LTD (INDUSTRY)
First posted
Last updated

Brief Summary

The RH210A is an air-conduction hearing aid designed for adults with perceived mild-to-moderate sensorineural hearing loss. The purpose of this clinical investigation is to generate objective and subjective evidence of the clinical performance and safety of the device.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑